Surface Oncology announced the appointments of Denice Torres to chair of the board of directors and Ben Hickey to board director. In conjunction with the board appointments, Jeff Goater will transition to board director. The company also announced internal promotions of key senior executives, naming Lisa McGrath chief people officer and Shannon Devens senior vice president, development operations. Denice Torres, MBA, J.D.has been a member of Surface’s board of directors since July 2021. Ms. Torres has over 25 years of executive leadership experience in healthcare across the consumer health, biopharmaceutical and medical device sectors. She is currently chief executive officer of The Ignited Company, a change management firm in the healthcare industry, and founder of The Mentoring Place, a non-profit, volunteer-based platform that accelerates the professional advancement of women through free executive-level mentorship. Previously, she held several executive leadership positions at Johnson & Johnson, including president of McNeil Consumer Healthcare, president of Janssen Pharmaceuticals, CNS and chief strategy and transformation officer for the Medical Device division. Before joining Johnson & Johnson, she had a highly successful 14-year career at Eli Lilly where she led a number of U.S. and global businesses. Ms. Torres is currently a director of bluebird bio, Karuna Therapeutics, Glaukos Corporation and Resilience. Ben Hickey, MBA has over 20 years of industry experience and is currently the chief commercial officer of Mirati Therapeutics, where he oversees all aspects of global commercialization, including pricing and access, sales and marketing, medical affairs, portfolio planning and patient advocacy. Prior to Mirati, Mr. Hickey was senior vice president and chief commercial officer at Halozyme Therapeutics, responsible for global commercial strategy for the company’s oncology portfolio. He spent 17 years in roles of increasing responsibility at Bristol Myers Squibb, including vice president of marketing, immuno-oncology, where he oversaw the commercialization of YERVOY®. Lisa McGrath, who joined Surface in 2017, was promoted to chief people officer. She previously served as senior vice president, human resources. Lisa brings over 20 years of experience driving impactful human resources initiatives, including targeted recruitment, performance management, competency development and employee engagement for publicly-traded, venture capital and angel-funded companies. Prior to Surface, she ran her own customized human resources practice specializing in biotech, pharmaceuticals, medical device and molecular diagnostics. In addition, Lisa has held senior human resources leadership positions at Synta Pharmaceuticals, Intelligent Medical Devices, Predictive BioSciences and BioSphere Medical. Shannon Devens, who has been with the company since 2016, was promoted to senior vice president, development operations. She has extensive experience with clinical development planning and execution with a focus on good clinical practice, operational infrastructure and outsourcing. Prior to joining Surface, Shannon served as senior director of clinical operations at Infinity Pharmaceuticals for more than seven years. Prior to that, she held roles in clinical operations at Molecular Insight Pharmaceuticals, Dyax Corp. and OmniSonics Medical Technologies.